Abbott Laboratories ABT
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.30B | 5.60B | 7.30B | 8.94B | 7.73B |
| Total Receivables | 9.03B | 8.60B | 8.21B | 7.93B | 8.14B |
| Inventory | 7.34B | 7.32B | 6.99B | 6.49B | 6.71B |
| Prepaid Expenses | 2.61B | 2.76B | 2.77B | 2.53B | 2.21B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 215.00M | 242.00M | 240.00M | 108.00M | 55.00M |
| Total Current Assets | 23.50B | 24.52B | 25.51B | 26.00B | 24.84B |
|
|
|||||
| Total Current Assets | 23.50B | 24.52B | 25.51B | 26.00B | 24.84B |
| Net Property, Plant & Equipment | 12.88B | 12.81B | 12.38B | 12.94B | 11.50B |
| Long-term Investments | 32.64B | 35.24B | 35.22B | 24.04B | 23.97B |
| Goodwill | 32.64B | 35.24B | 35.22B | 24.04B | 23.97B |
| Total Other Intangibles | 19.59B | 17.21B | 17.88B | 5.53B | 5.60B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.86B | 18.65B | 18.67B | 17.62B | 17.64B |
| Total Assets | 108.25B | 109.22B | 110.43B | 86.71B | 84.18B |
|
|
|||||
| Total Accounts Payable | 4.66B | 4.79B | 4.68B | 4.24B | 4.12B |
| Total Accrued Expenses | 8.29B | 8.30B | 7.36B | 7.17B | 7.31B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.72B | 3.02B | 4.43B | 3.31B | 1.35B |
| Total Finance Division Other Current Liabilities | 1.49B | 1.70B | 1.91B | 1.77B | 1.80B |
| Total Other Current Liabilities | 1.49B | 1.70B | 1.91B | 1.77B | 1.80B |
| Total Current Liabilities | 16.15B | 17.81B | 18.38B | 16.50B | 14.58B |
|
|
|||||
| Total Current Liabilities | 16.15B | 17.81B | 18.38B | 16.50B | 14.58B |
| Long-Term Debt | 29.72B | 29.70B | 29.71B | 9.90B | 11.63B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 931.00M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.75B | 9.94B | 9.65B | 6.62B | 6.71B |
| Total Liabilities | 56.62B | 57.45B | 57.73B | 33.94B | 32.92B |
|
|
|||||
| Common Stock & APIC | 25.65B | 25.50B | 25.35B | 25.53B | 25.41B |
| Retained Earnings | 49.64B | 49.79B | 49.96B | 49.78B | 49.10B |
| Treasury Stock & Other | -24.26B | -24.18B | -23.25B | -23.18B | -23.56B |
| Total Common Equity | 51.03B | 51.11B | 52.06B | 52.13B | 50.95B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.03B | 51.11B | 52.06B | 52.13B | 50.95B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 596.00M | 652.00M | 640.00M | 641.00M | 310.00M |
| Total Equity | 51.62B | 51.76B | 52.70B | 52.77B | 51.26B |
|
|
|||||